Epilamba Junior shortlisted for the CPHI Pharma Awards 2026

Epilamba Junior by Cor.Con. International has been shortlisted as a finalist for the CPHI Pharma Awards 2026 in the Finished Formulation category.

Metabolic System

Epilepsy

Central Nervous System

Gynecology

Immune Defense

Cardiovascular

Consumer Healthcare